A Long-Term Follow-Up and Comprehensive Observation of Risk and Prognosis Factors of Recurrence and Survival After Resection of Hepatocellular Carcinoma

Cell Biochemistry and Biophysics

Volumn 69, Issue 3, 2014, Pages 421-431

  Hu, Lei ^a   Xue, Feng ^a   Li, Yunyun ^a   Shao, Minhua ^b   Sun, Yanfu ^a   Wei, Gongtian ^a  

^a The Fourth Department of Liver Surgery Eastern Hepatobiliary Hospital Affiliated to the Second Military Medicine College   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Disease free survival; Hepatocellular carcinoma; Overall survival; Prognosis

Indexed keywords

HEPATITIS B VIRUS;

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; LIVER NEOPLASMS; LIVER RESECTION; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSIOLOGY; POSTOPERATIVE PERIOD; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84902377178     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9813-3     Document Type: Article

References (31)

1. Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001). Estimating the world cancer burden: GLOBOCAN 2000. International Journal of Cancer, 94(2), 153-156.
2. Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55(2), 74-108.
3. Sherman, M. (2005). Hepatocellular carcinoma: epidemiology, risk factors, and screening [Review]. Seminars in Liver Disease, 25(2), 143-154.
4. Yamamoto, J., Okada, S., Shimada, K., Okusaka, T., Yamasaki, S., Ueno, H., et al. (2001). Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology, 34(4 Pt 1), 707-713.
5. Chen, M. S., Li, J. Q., Zheng, Y., Guo, R. P., Liang, H. H., Zhang, Y. Q., et al. (2006). A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Annals of Surgery, 243(3), 321-328.
6. Jianyong, L., Xuejun, K., Yinnong, Z., Zhiming, Z., Weiping, Y., Qingguo, M., et al. (2009). Analysis of risk factors influencing intrahepatic recurrence of hepatocellular carcinoma after curative resection. Chinese Journal of Operative Procedures of General Surgery, 3(4), 008-010.
7. Nanashima, A., Abo, T., Hamasaki, K., Wakata, K., Tominaga, T., Hidaka, S., et al. (2011). Perioperative non-tumorous factors associated with survival in HCC patients who underwent hepatectomy. Anticancer Research, 31(12), 4545-4551.
8. Yang, T., Zhang, J., Lu, J. H., Yang, G. S., Wu, M. C., & Yu, W. F. (2011). Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World Journal of Surgery, 35(9), 2073-2082.
9. Kumar, M., Kumar, R., Hissar, S. S., Saraswat, M. K., Sharma, B. C., Sakhuja, P., et al. (2007). Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A case-control study of 213 hepatocellular carcinoma patients from India. Journal of Gastroenterology and Hepatology, 22(7), 1104-1111.
10. Schlaeger, C., Longerich, T., Schiller, C., Bewerunge, P., Mehrabi, A., Toedt, G., et al. (2008). Etiology-dependent molecular mechanisms in human hepatocarcinogenesis [Research Support, Non-US Gov't]. Hepatology, 47(2), 511-520.
11. Schwalbe, M., Ohlenschlager, O., Marchanka, A., Ramachandran, R., Hafner, S., Heise, T., et al. (2008). Solution structure of stem-loop alpha of the hepatitis B virus post-transcriptional regulatory element. Nucleic Acids Research, 36(5), 1681-1689.
12. Memon, K., Kulik, L., Lewandowski, R. J., Wang, E., Ryu, R. K., Riaz, A., et al. (2012). Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis [Research Support, N. I. H., Extramural]. Journal of Hepatology, 56(5), 1112-1120.
13. Yang, H. I., Lu, S. N., Liaw, Y. F., You, S. L., Sun, C. A., Wang, L. Y., et al. (2002). Hepatitis B e antigen and the risk of hepatocellular carcinoma [Research Support, Non-US Gov't]. The New England Journal of Medicine, 347(3), 168-174.
14. Kubo, S., Hirohashi, K., Tanaka, H., Tsukamoto, T., Shuto, T., Yamamoto, T., et al. (2000). Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma [Research Support, Non-US Gov't]. Cancer, 88(5), 1016-1024.
15. Kubo, S., Hirohashi, K., Yamazaki, O., Matsuyama, M., Tanaka, H., Horii, K., et al. (2002). Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B [Research Support, Non-US Gov't]. World Journal of Surgery, 26(5), 555-560.
16. Yang, P., Li, Q. J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., et al. (2012). TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell, 22(3), 291-303.
17. Kaibori, M., Tanigawa, N., Matsui, Y., Kwon, A. H., Sawada, S., & Kamiyama, Y. (2004). Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma [Clinical Trial Randomized Controlled Trial]. Anticancer Research, 24(3b), 1929-1933.
18. Ohata, K., Hamasaki, K., Toriyama, K., Ishikawa, H., Nakao, K., & Eguchi, K. (2004). High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Journal of Gastroenterology and Hepatology, 19(6), 670-675.
19. Hanazaki, K., Kajikawa, S., Shimozawa, N., Mihara, M., Shimada, K., Hiraguri, M., et al. (2000). Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. Journal of the American College of Surgeons, 191(4), 381-388.
20. Capussotti, L., Muratore, A., Amisano, M., Polastri, R., Bouzari, H., & Massucco, P. (2005). Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival-A European single center experience. European Journal of Surgical Oncology, 31(9), 986-993.
21. Hanazaki, K., Matsushita, A., Nakagawa, K., Misawa, R., & Amano, J. (2005). Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma. Hepato-Gastroenterology, 52(62), 552-557.
22. Peng, S. Y., Chen, W. J., Lai, P. L., Jeng, Y. M., Sheu, J. C., & Hsu, H. C. (2004). High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and beta-catenin mutations [Research Support, Non-US Gov't]. International Journal of Cancer Journal International du Cancer, 112(1), 44-50.
23. Tung-Ping Poon, R., Fan, S. T., & Wong, J. (2000). Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma [Review]. Annals of Surgery, 232(1), 10-24.
24. Leone, N., & Rizzetto, M. (2005). Screening for hepatocellular carcinoma] [Review. Minerva Medica, 96(2), 95-108. ita.
25. Ren, F. Y., Piao, X. X., & Jin, A. L. (2006). Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma [Evaluation Studies]. World Journal of Gastroenterology, 12(29), 4656-4659.
26. Soresi, M., Magliarisi, C., Campagna, P., Leto, G., Bonfissuto, G., Riili, A., et al. (2003). Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma [Research Support, Non-US Gov't]. Anticancer Research, 23(2C), 1747-1753.
27. Tateishi, R., Yoshida, H., Matsuyama, Y., Mine, N., Kondo, Y., & Omata, M. (2008). Diagnostic accuracy of tumor markers for hepatocellular carcinoma: A systematic review. Hepatology International, 2(1), 17-30.
28. Weiju, S. (2007). Alpha-fetoprotein changing and tumor recurrence after liver transplantation for patients with hepatocellular carcinoma. Hangzhou: Zhejiang University.
29. Hui-chuan, S., Wei, Z., Lun-xiu, Q., Qing-hai, Y., Lu, W., Ning, R., et al. (2007). Effect of preoperative serum HBeAg status on recurrence and survival in hepatocellular carcinoma patients after radical Resection. Chinese Journal of Bases and Clinics in General Surgery, 14, 32-37.
30. Poon, R. T., Fan, S. T., Ng, I. O., Lo, C. M., Liu, C. L., & Wong, J. (2000). Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer, 89(3), 500-507.
31. Ochiai, T., Ikoma, H., Okamoto, K., Kokuba, Y., Sonoyama, T., & Otsuji, E. (2012). Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection. World Journal of Surgery, 36(1), 136-143.